Letrozole, an aromatase inhibitor, is frequently prescribed to induce ovulation in individuals experiencing infertility. A common protocol involves administering this medication orally from the second to the sixth day of the menstrual cycle. The query “when will I ovulate” during this treatment window is a natural concern for individuals undergoing this protocol. Successful ovulation is the primary goal of letrozole therapy.
Understanding the expected timeframe for ovulation following this regimen is crucial for optimizing the chances of conception. Knowing the potential ovulation window allows for properly timed intercourse or intrauterine insemination, maximizing the likelihood of pregnancy. The historical context of letrozole usage for ovulation induction highlights its effectiveness and favorable side effect profile compared to other fertility medications.